Posted On: 12/23/2012 3:24:18 PM
Post# of 72446
http://www.nytimes.com/2012/12/23/health/new-...s&_r=0
Anyone understand the science well enough to venture a guess as to why our approach might succeed relative to others? The article above mentions 3 competitors in the p53 approach; Sanfi, Merck and Roche.....some BIG BOYS with deep pockets!
(0)
(0)
